Stella Wang

Bristol Myers Squibb

BIOGRAPHY

Stella Wang, a Scientist at Bristol-Myers Squibb, focuses on in vitro and in vivo biopharmaceutics risk assessment for both small molecule and parenteral assets. She has been instrumental in method development and in vitro release studies to support technology and formulation screening for small molecule assets as long-acting injectables. 

At the exploratory biopharmaceutics group, Stella contributes to advancing innovative pharmaceutical products. Her talk will highlight recent work in this area, sharing insights into the development process and challenges overcome.